IKT Operating Cash Flow (Statement)
Inhibikase Therapeutics Inc · Operating Cash Flow (Statement)
IKT Operating Cash Flow (Statement)
Latest reported-$42.61Mperiod ending
IKT Cash from Operations (-$29.57K → -$42.61M)
Annual operating cash flow (statement)
High-resolution chart · PNG
IKT operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -27,786,464 | |
| -19,148,067 | |
| -18,085,043 | |
| -17,351,103 | |
| -14,297,051 | |
| -1,129,355 | |
| -338,290 | |
| 714,987 | |
| -126,391 | |
| -29,573 |